MRD Prognostic of Poorer Outcomes in AML
Molecular minimal residual disease was associated with a higher rate of relapse and a lower rate of relapse-free survival and overall survival for patients with newly-diagnosed acute myeloid leukemia.
Read full article (External website)
Leave a Reply
Want to join the discussion?Feel free to contribute!